Influence of mitochondrial inhibition on global and local [Ca(2+)](I) in rat tail artery

Circ Res. 2002 Apr 19;90(7):792-9. doi: 10.1161/01.res.0000015214.40360.84.

Abstract

Inhibition of oxidative metabolism is often found to decrease contractility of systemic vascular smooth muscle, but not to reduce global [Ca(2+)](i). In the present study, we probe the hypothesis that it is associated with an altered pattern of intracellular Ca(2+) oscillations (waves) influencing force development. In the rat tail artery, mitochondrial inhibitors (rotenone, antimycin A, and cyanide) reduced alpha(1)-adrenoceptor-stimulated force by 50% to 80%, but did not reduce global [Ca(2+)](i). Less relaxation (about 30%) was observed after inhibition of myosin phosphatase activity with calyculin A, suggesting that part of the metabolic sensitivity involves the regulation of myosin 20-kDa light chain phosphorylation, although no decrease in phosphorylation was found in freeze-clamped tissue. Confocal imaging revealed that the mitochondrial inhibitors increased the frequency but reduced the amplitude of asynchronous cellular Ca(2+) waves elicited by alpha(1) stimulation. The altered wave pattern, in association with increased basal [Ca(2+)](i), accounted for the unchanged global [Ca(2+)](i). Inhibition of glycolytic ATP production by arsenate caused similar effects on Ca(2+) waves and global [Ca(2+)](i), developing gradually in parallel with decreased contractility. Inhibition of wave activity by the InsP(3) receptor antagonist 2-APB correlated closely with relaxation. Furthermore, abolition of waves with thapsigargin in the presence of verapamil reduced force by about 50%, despite unaltered global [Ca(2+)](i), suggesting that contraction may at least partly depend on Ca(2+) wave activity. This study therefore indicates that mitochondrial inhibition influences Ca(2+) wave activity, possibly due to a close spatial relationship of mitochondria and the sarcoplasmic reticulum and that this contributes to metabolic vascular relaxation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-Agonists / pharmacology
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Antimycin A / pharmacology
  • Arsenates / pharmacology
  • Arteries / drug effects
  • Arteries / metabolism*
  • Calcium / metabolism*
  • Calcium Signaling / drug effects
  • Calcium Signaling / physiology
  • Cyanides / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Female
  • Glycolysis / drug effects
  • In Vitro Techniques
  • Intracellular Fluid / metabolism*
  • Isometric Contraction / drug effects
  • Mitochondria / drug effects*
  • Mitochondria / metabolism*
  • Myosin Light Chains / metabolism
  • Phosphorylation / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Adrenergic, alpha-1 / metabolism
  • Rotenone / pharmacology
  • Tail / blood supply
  • Uncoupling Agents / pharmacology
  • Vasoconstriction / drug effects

Substances

  • Adrenergic alpha-Agonists
  • Anti-Bacterial Agents
  • Arsenates
  • Cyanides
  • Enzyme Inhibitors
  • Myosin Light Chains
  • Receptors, Adrenergic, alpha-1
  • Uncoupling Agents
  • Rotenone
  • Antimycin A
  • arsenic acid
  • Calcium